Neurology in Colorado

D.O. Weaver and Company is a leading manufacturer of EEG and ECG electrode preparation and conductive products for cardiac diagnostics, sleep diagnostics, and electroneurodiagnostics applications. Based in Aurora, Colorado, the company specializes in high-performance skin prep gels and conductive pastes designed to reduce impedance and improve signal quality in diagnostic monitoring. Their flagship products—Nuprep Skin Prep Gel and Ten20 Conductive Paste—are trusted by technologists and technicians worldwide for reliable electrode adhesion and conductivity. ISO 13485 certified, Weaver and Company maintains rigorous manufacturing standards and distributes globally through an established distributor network.

UltraThera Technologies, Inc. manufactures GyroStim, an FDA-cleared Breakthrough Device for multimodal neurorehabilitation. GyroStim is a precision neurotechnology platform engineered to accelerate recovery from concussion, mild traumatic brain injury (mTBI), and vestibular dysfunction. The device combines rotational motion with precisely dosed therapeutic protocols to address balance disorders and neurological impairments. Clinical evidence demonstrates up to 8× faster rehabilitation rates compared to conventional therapy alone. FDA-cleared under K220231 for treatment of balance disorders and vestibular dysfunction, GyroStim holds the rare FDA Breakthrough Device designation, recognizing its capability to significantly advance standard-of-care outcomes. The system has been in continuous clinical use since 2010 with zero reported injuries. GyroStim is accessible to patients across a broad severity spectrum, including those with severe physical or cognitive disabilities who may not tolerate traditional therapies. The platform is used by elite athletes, military personnel, civilians, and patients in specialized neurorehabilitation centers worldwide. Applications include sports-related concussion recovery, traumatic brain injury rehabilitation, vestibular rehabilitation, and performance optimization. The company provides clinical outcome data, physician training, and patient support services. Manufacturing and regulatory compliance align with medical device standards for rehabilitation and neurological therapeutic equipment.

Neuralytix develops proprietary mechanomyography (MMG) technology for intraoperative nerve assessment during spinal surgery. The FDA-cleared iD3 System provides surgeons with real-time, objective measurements of nerve function through non-invasive accelerometer sensors, replacing subjective tactile feedback and invasive EMG. The system assists in nerve locating, mapping, and decompression assessment across minimally invasive and open spinal procedures, including fusion, discectomy, laminectomy, and foraminotomy. MMG enables surgeons to quantify neural response threshold changes throughout surgery, improving decision-making precision and reducing reoperation risk while eliminating procedural complexity associated with traditional EMG monitoring.

Neurotron, Incorporated is a US-based medical device manufacturer established in 1981, headquartered in Aurora, Colorado. The company specializes in the Neurometer® CPT® (Current Perception Threshold), a proprietary neurodiagnostic device for painless, non-invasive sensory nerve fiber testing. The Neurometer® CPT® evaluates small unmyelinated C-fibers, small myelinated Aδ-fibers, and large myelinated Aβ-fibers at any cutaneous site, detecting >90% of sensory nerve fiber types using a standardized, double-blind automated test procedure. FDA-cleared since 1986, the device has been used in over one million tests globally and is supported by more than 800 peer-reviewed publications. The technology quantifies both hyperesthesia and hypoesthesia, monitors nerve regeneration progression, and enables early detection of nerve damage from diabetes, carpal tunnel syndrome, spinal injury, sciatica, radiculopathy, and polyneuropathy. Unlike traditional electrodiagnostic and biopsy procedures, CPT® measurements are unaffected by skin temperature, edema, or electromagnetic interference. The device is portable, battery-powered, painless, non-invasive, and requires no special environmental shielding. Neuval® CPT® software evaluates results against established norms, manages patient records, and generates clinical reports. The company markets through direct sales and an international distributor network across China, Japan, Switzerland, Korea, Benelux, UAE, and Kuwait. Products are manufactured in the USA.

3D-Side is a software and patient-specific medical device company specializing in AI-powered 3D preoperative planning and personalized healthcare solutions. The company operates a cloud-based platform called Customize, which integrates case management, communication, quality management, and full traceability for patient-specific medical device production. The platform supports three main product lines: 3D-Arthro (arthroplasty planning and patient-specific instrumentation for shoulder and ankle, with FDA 510(k) clearance), 3D-Cut (bone tumor resection and corrective osteotomy cutting guides), and 3D-Skull (cranioplasty solutions with AI-based segmentation and custom cranial implant design). 3D-Side targets neurosurgeons, orthopedic surgeons, arthroplasty implant manufacturers, and patient-specific device manufacturers. The platform covers the entire surgical journey from preoperative planning through intraoperative execution to postoperative surveillance. The Customize platform features AI automation for segmentation, communication, document generation, and case management, enabling scalable production of patient-specific devices. The company designs turnkey solutions tailored to customer implant philosophy and surgical approach, with rapid design and manufacturing capabilities. 3D-Skull specializes in cranioplasty molds for intraoperative PMMA implant creation, reducing lead times and manufacturing costs.

WAVi Co manufactures the WAVi Scan, an FDA-cleared Class II EEG system designed for objective brain assessments in clinical, research, and performance contexts. The integrated platform combines a comfortable wet EEG headset (requiring no gel), cloud-connected software with guided protocols, and automated reporting. WAVi Scan includes evoked response testing (P300), Flanker tasks, and Trail Making Test assessments, with output metrics covering brain response voltage, latency, and quantitative EEG (QEEG) measures compared to reference ranges. The system is designed for non-specialist operation, with typical patient setup in 5–10 minutes and no requirement for specialized neurology staff. Primary applications include injury and performance monitoring (baseline/follow-up, return-to-activity programs, post-event documentation), longitudinal wellness tracking in primary care settings, and research initiatives. WAVi has been integrated into university research programs and institutional collaborations including NIH-affiliated studies and academic medical centers. The platform emphasizes structured workflow, training support via a user portal, and professional review functionality for qualified clinicians. Regulatory status: FDA 510(k) clearance as Class II medical device.